Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eng Huat Tan

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapyMaciej Krzakowski, Rodryg Ramlau, Jacek Jassem, et al.
Molecular Cancer|January 28, 2014
Bosutinib inhibits migration and invasion via ACK1 in KRAS mutant non-small cell lung cancerDaniel S W Tan, Benjamin Haaland, Jia Min Gan, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2015
Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancerEng Huat Tan, Daniel Shao Weng Tan, Wen Yun Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varietyJoseph Wee, Eng Huat Tan, Bee Choo Tai, et al.
The New England Journal of Medicine|July 15, 2005
Erlotinib in previously treated non-small-cell lung cancerFrances A Shepherd, José Rodrigues Pereira, Tudor Ciuleanu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 11, 2021
Intratumoral CD39<sup>+</sup>CD8<sup>+</sup> T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLCJoe Yeong, Lisda Suteja, Yannick Simoni, et al.
Clinical Lung Cancer|June 24, 2014
Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01)Jaafar Bennouna, Libor Havel, Maciej Krzakowski, et al.
Frontiers in Oncology|July 26, 2021
Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb StudiesAntonio Passaro, Filippo de Marinis, Hai-Yan Tu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 4, 2013
Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinomaWhay-Kuang Chia, Marissa Teo, Who-Whong Wang, et al.
The Lancet. Oncology|March 29, 2012
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trialVincent A Miller, Vera Hirsh, Jacques Cadranel, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapyMaciej Krzakowski, Rodryg Ramlau, Jacek Jassem, et al.
Molecular Cancer|January 28, 2014
Bosutinib inhibits migration and invasion via ACK1 in KRAS mutant non-small cell lung cancerDaniel S W Tan, Benjamin Haaland, Jia Min Gan, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2015
Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancerEng Huat Tan, Daniel Shao Weng Tan, Wen Yun Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varietyJoseph Wee, Eng Huat Tan, Bee Choo Tai, et al.
The New England Journal of Medicine|July 15, 2005
Erlotinib in previously treated non-small-cell lung cancerFrances A Shepherd, José Rodrigues Pereira, Tudor Ciuleanu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 11, 2021
Intratumoral CD39<sup>+</sup>CD8<sup>+</sup> T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLCJoe Yeong, Lisda Suteja, Yannick Simoni, et al.
Clinical Lung Cancer|June 24, 2014
Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01)Jaafar Bennouna, Libor Havel, Maciej Krzakowski, et al.
Frontiers in Oncology|July 26, 2021
Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb StudiesAntonio Passaro, Filippo de Marinis, Hai-Yan Tu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 4, 2013
Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinomaWhay-Kuang Chia, Marissa Teo, Who-Whong Wang, et al.
The Lancet. Oncology|March 29, 2012
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trialVincent A Miller, Vera Hirsh, Jacques Cadranel, et al.
Pageof 11